Final Word: Advocating for Biosimilar Approval Standards under BPCI
September 1, 2011
Chad A. Landmon
BioPharm International
Axinn partner Chad Landmon's article, "Final Word: Advocating for Biosimilar Approval Standards under BPCI" was published by BioPharm International.